mechanism

amyloid_clearance

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about amyloid_clearance: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

21Connections

26Hypotheses

18Analyses

2Outgoing

19Incoming

6Experiments

20Debates

Summary

A mechanism referenced in 2 knowledge graph relationships. Key connections: phagocytosis (mechanism) promotes; protective_against alzheimers (disease).

View on Wiki →

No AI portrait yet

⚙ Mechanism Info

Name	amyloid_clearance
Key Genes/Proteins	ACE, APOE, apoE4, APOE4, apolipoprotein_E, CSF p-tau217 reduction
Related Diseases	apoe3, Clinical benefits, Cognitive Recovery
Related Pathways	SYK signaling
Linked Hypotheses	23 hypotheses

Wiki Pages (1)

Knowledge base pages for this entity

Validated Hypothesis: Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymphatic enhancement and amyloid clearance from PV interneurons in Alzheimer's disease

hypothesis · 4477 words

→

Pathway Diagram

graph TD
    amyloid_clearance["amyloid_clearance"]
    apolipoprotein_E("apolipoprotein_E")
    apolipoprotein_E -->|"regulates"| amyloid_clearance
    APOE4_domain_interaction["APOE4_domain_interaction"]
    APOE4_domain_interaction -->|"impairs"| amyloid_clearance
    ACE["ACE"]
    ACE -->|"enhances"| amyloid_clearance

Outgoing (2)

Target	Relation	Type	Str
Clinical benefits	causes	phenotype	0.70
Cognitive Recovery	causes	phenotype	0.70

Incoming (19)

Source	Relation	Type	Str
TREM2	enhances	gene	0.90
apolipoprotein_E	regulates	protein	0.80
APOE4_domain_interaction	impairs	structural_defect	0.80
microglia	performs	cell_type	0.70
APOE4	inhibits	protein	0.70
APOE	associated_with	gene	0.70
apoE4	associated_with	protein	0.70
apoe3	activates	disease	0.70
TREM2 Agonistic Antibodies	enhances	drug	0.70
Trem2	mediates	protein	0.70
reduced_lipid_binding	inhibits	gene	0.70
CSF p-tau217 reduction	biomarker_for	gene	0.70
TREM2 activation	regulates	phenotype	0.70
TREM2-SYK signaling cascade	associated_with	pathway	0.70
SYK signaling	associated_with	pathway	0.70
Trem2 Agonism	enhances	phenotype	0.70
ACE	NULL	gene	0.50
ACE	enhances	gene	0.50
IL-10R agonist	associated_with	drug	0.50

Targeting Hypotheses (26)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Closed-loop transcranial focused ultrasound to restore hippo	0.827	alzheimers	Circuit-level neural dynamics in neurode
CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-S	0.811	neurodegeneration	What are the cell-type-specific transcri
Test: TREM2 enhances amyloid clearance	0.755	-	Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance	0.712	-	Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance	0.705	-	Test Hypothesis Fixtures

TREM2 Microglial Activation Rescues Amyloid Clearance in AD	0.682	neurodegeneration	Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance	0.655	-	Test Hypothesis Fixtures
H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from	0.644	neurodegeneration	TREM2 in Alzheimer's Disease: Mechanisms
Test: TREM2 enhances amyloid clearance	0.637	-	Test Hypothesis Fixtures
Microglial ACE Enhancement for Amyloid Clearance	0.622	neurodegeneration	Gene expression changes in aging mouse b
Test: TREM2 enhances amyloid clearance	0.612	-	Test Hypothesis Fixtures
Closed-loop transcranial focused ultrasound to restore hippo	0.564	alzheimers	Circuit-level neural dynamics in neurode
Test: TREM2 enhances amyloid clearance	0.555	-	Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance	0.541	-	Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance	0.541	-	Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance	0.541	-	Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance	0.541	-	Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance	0.541	-	Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance	0.537	-	Test Hypothesis Fixtures
Gut-derived butyrate reprograms microglia for amyloid cleara	0.525	alzheimers	Gut-Brain Axis Therapeutics for AD
Microglial Reactivation Status Modifies Amyloid Clearance an	0.524	neurodegeneration	-
Test: TREM2 enhances amyloid clearance	0.512	-	Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance	0.437	-	Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance	0.400	-	Test Hypothesis Fixtures
Gut butyrate deficiency impairs microglial amyloid clearance	0.380	alzheimers	Gut-Brain Axis Therapeutics for Alzheime
Axonal Integrity Recovery Following Amyloid Clearance Drives	0.365	-	Can CSF p-tau217 normalization serve as

Mentioning Analyses (18)

Scientific analyses that reference this entity

APOE ε4 Lipid Metabolism Differences in Microglial Subpopulations and Amyloid Cl

neurodegeneration | 2026-04-27 | 1 hypotheses Top: 0.697

What amyloid threshold level is required for optimal clinical benefit in early A

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.577

How does HDAC1/2 deletion specifically enhance microglial amyloid phagocytosis c

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.444

Is C1q elevation in AD pathogenic or compensatory for amyloid clearance?

neurodegeneration | 2026-04-12 | 0 hypotheses

What are the optimal timing windows for TREM2 agonism vs antagonism across disea

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (6)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.800	0.00	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.800	0.00	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.800	0.00	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.800	0.00	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.800	0.00	Mouse (5xFAD/TREM2-/-)	completed	N/A
Closed-loop tFUS Enhances Glymphatic Clearance and Restores CA1 PV Int	in_vivo	Alzheimer's disease	0.765	0.55	APP/PS1 mice 8-11 months (n=10	abandoned	$125,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797]	Zhou Y, Song WM, Andhey PS, Swain A, Lev	Nat Med	2020	1
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clin [PMID:41324786]	Abushakra S, Doraiswamy PM, Hey JA, Tosu	CNS drugs	2026	0
Adverse childhood experiences and cardiometabolic risk factors in people with bi [PMID:40935250]	Turner A, Kuperberg M, McGovern H, Wrobe	J Affect Disord	2026	0
Indole-3-propionic acid links gut dysfunction to diabetic retinopathy: a biomark [PMID:41198173]	Prasad R, Adu-Rutledge Y, Ziani B, Floyd	Gut	2026	0
Amyloidosis of bridging veins is a pathologic feature of Alzheimer's disease. [PMID:41329157]	Smyth LCD, Verhaege D, Standen-Bloom E,	J Exp Med	2026	0
Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of [PMID:41422555]	Mishra AK, Jain S	ACS Chem Neurosci	2026	0
A minimally invasive dried blood spot biomarker test for the detection of Alzhei [PMID:41491101]	Huber H, Montoliu-Gaya L, Brum WS, Vávra	Nat Med	2026	0
Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649]	Zhang J, St Pierre Schneider B, Muguerza	Am J Physiol Endocrinol Metab	2026	0
[Polypharmacy and nephrotoxicity]. [PMID:41535444]	Czock D, Ebinger K, Sommerer C	Inn Med (Heidelb)	2026	0
The association of Alzheimer's disease-related SNPs with mild cognitive impairme [PMID:41606232]	Xie Z, Tu W, Ye XF, Hua L, Zhang X et al	Sci Rep	2026	0
Association between sleep duration and fluid biomarkers of Alzheimer's disease: [PMID:41610733]	Young VM, Zeynoun J, Ruiz Laza A, Salard	Sleep Med Rev	2026	0
Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial. [PMID:41618732]	Kantarci K, Kara F, Tosakulwong N, Fough	Alzheimers Dement	2026	0
Genetic risk factors of late-onset Alzheimer's disease: Insights into pathophysi [PMID:41622452]	Akkaoui J, Devadoss D, Rodriguez MD, Ari	Neural Regen Res	2026	0
Plasma ATN biomarkers across the alzheimer's disease continuum in a Chilean comm [PMID:41691306]	Orellana P, Henríquez F, Cabral-Miranda	Alzheimers Res Ther	2026	0
Neuro-renin-angiotensin-aldosterone system axis in alzheimer's disease: from mol [PMID:41706377]	Singh G, Maparu K, Aran KR	Metab Brain Dis	2026	0
Genetic Burden and <i>APOE</i> Methylation in a Korean Multi-Generational Alzhei [PMID:41745359]	Eom Je-Hyun; Cho Mu-Yeol; Kim Ji-Won; Ki	Journal of personalized medici	2026	0
Renin-angiotensin system blockade attenuates brain mitochondrial dysfunction, ox [PMID:41883437]	García Menéndez S, Inserra F, de Cavanag	World J Exp Med	2026	0
Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052]	Burdman Gabriel; Akkaoui Juliet; Colon N	Neurology international	2026	0
Association Between ACE (I/D) Polymorphism and Essential Hypertension (EH): An U [PMID:41899774]	Smallwood A, Akam E, Hunter DJ, Singh M,	Int J Environ Res Public Healt	2026	0
Posttraumatic stress disorder is associated with Alzheimer's disease-relevant mo [PMID:41960318]	Seijo MA, Yohannes PA, Rogers AL, Gonzal	Res Sq	2026	0

Debates (20)

Multi-agent debates referencing this entity

Second debate: Microglial TREM2-SYK Pathway Enhancement

closed · Rounds: 4 · Score: 0.57 · 2026-04-28

How do APOE4-driven lipid droplet and cholesterol-metabolism differences in micr

closed · Rounds: 4 · Score: 0.76 · 2026-04-28

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

closed · Rounds: 4 · Score: 0.12 · 2026-04-27

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

closed · Rounds: 4 · Score: 0.42 · 2026-04-27

Debate: LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability i

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes

closed · Rounds: 4 · Score: 0.47 · 2026-04-27

Debate: Microglial TREM2 downregulation impairs damage-associated response in la

closed · Rounds: 4 · Score: 0.21 · 2026-04-27

Should '40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Sele

closed · Rounds: 4 · Score: 0.52 · 2026-04-27

Should 'ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matt

closed · Rounds: 4 · Score: 0.72 · 2026-04-27

Hypothesis debate: Multi-Biomarker Composite Index Surpassing Amyloid PET for Tr

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Related Research

Hypotheses and analyses mentioning amyloid_clearance in their description or question text

TREM2 Microglial Activation Rescues Amyloid Clearance in AD

Score: 0.682 · neurodegeneration · 2026-04-26

TREM2 agonistic antibodies restore microglial phagocytosis and plaque compaction in Alzheimer's disease, particularly fo

Test: TREM2 enhances amyloid clearance

Score: 0.655 · unknown disease · 2026-04-17

**Molecular Mechanism and Rationale** TREM2 (Triggering Receptor Expressed on Myeloid cells 2) represents a critical mi

H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from Synapse Pruning to A

Score: 0.644 · neurodegeneration · 2026-04-14

## Mechanistic Overview H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from Synapse Pruning to Amyloid Clearance

Test: TREM2 enhances amyloid clearance

Score: 0.637 · unknown disease · 2026-04-17

**Molecular Mechanism and Rationale** TREM2 (Triggering Receptor Expressed on Myeloid cells 2) functions as a critical

Microglial ACE Enhancement for Amyloid Clearance

Score: 0.622 · neurodegeneration · 2026-04-04

## Mechanistic Overview Microglial ACE Enhancement for Amyloid Clearance starts from the claim that modulating ACE withi

Test: TREM2 enhances amyloid clearance

Score: 0.612 · unknown disease · 2026-04-17

**Molecular Mechanism and Rationale** TREM2 (Triggering Receptor Expressed on Myeloid cells 2) functions as a crucial i

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Score: 0.564 · alzheimers · 2026-04-17

## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymph